Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Alan J. Levy sold 2,997 shares of the stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $371.35, for a total transaction of $1,112,935.95. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Shares of Intuitive Surgical, Inc. (NASDAQ ISRG) traded down $0.85 during midday trading on Friday, hitting $389.15. 686,600 shares of the stock were exchanged, compared to its average volume of 974,466. The firm has a market capitalization of $43,698.64, a PE ratio of 51.61, a P/E/G ratio of 5.46 and a beta of 0.47. Intuitive Surgical, Inc. has a 52-week low of $203.57 and a 52-week high of $393.51.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.78. Intuitive Surgical had a net margin of 30.16% and a return on equity of 18.20%. The firm had revenue of $806.10 million during the quarter, compared to analysts’ expectations of $753.25 million. During the same period last year, the company earned $2.06 earnings per share. The business’s revenue was up 18.0% on a year-over-year basis. equities research analysts predict that Intuitive Surgical, Inc. will post 7.85 earnings per share for the current fiscal year.
WARNING: “Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Sells 2,997 Shares of Stock” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this report can be read at https://www.dispatchtribunal.com/2017/11/11/alan-j-levy-sells-2997-shares-of-intuitive-surgical-inc-isrg-stock.html.
A number of institutional investors have recently added to or reduced their stakes in the stock. FMR LLC boosted its holdings in Intuitive Surgical by 19.6% during the second quarter. FMR LLC now owns 2,724,964 shares of the medical equipment provider’s stock worth $2,548,849,000 after purchasing an additional 447,397 shares during the last quarter. Vanguard Group Inc. boosted its holdings in Intuitive Surgical by 0.8% during the second quarter. Vanguard Group Inc. now owns 2,524,027 shares of the medical equipment provider’s stock worth $2,360,900,000 after purchasing an additional 20,210 shares during the last quarter. Koch Industries Inc. boosted its holdings in Intuitive Surgical by 202,917.0% during the second quarter. Koch Industries Inc. now owns 1,388,636 shares of the medical equipment provider’s stock worth $1,387,000 after purchasing an additional 1,387,952 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in Intuitive Surgical by 3.3% during the second quarter. Alliancebernstein L.P. now owns 690,780 shares of the medical equipment provider’s stock worth $646,135,000 after purchasing an additional 21,795 shares during the last quarter. Finally, American Century Companies Inc. boosted its holdings in Intuitive Surgical by 1.6% during the second quarter. American Century Companies Inc. now owns 560,621 shares of the medical equipment provider’s stock worth $524,388,000 after purchasing an additional 8,629 shares during the last quarter. Institutional investors and hedge funds own 31.43% of the company’s stock.
A number of brokerages have recently issued reports on ISRG. Vetr cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $111.83 target price on the stock. in a report on Wednesday, August 16th. BidaskClub cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, August 1st. Barclays PLC increased their price target on shares of Intuitive Surgical from $96.67 to $111.11 and gave the company an “overweight” rating in a report on Friday, July 21st. They noted that the move was a valuation call. J P Morgan Chase & Co reissued an “overweight” rating and issued a $116.67 price target on shares of Intuitive Surgical in a report on Friday, July 21st. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $118.89 target price (up from $105.56) on shares of Intuitive Surgical in a report on Tuesday, July 25th. Five equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $154.72.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.